Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
This observational study aims to study the effectiveness and safety of Obinutuzumab in common
 clinical practice settings in Argentina. The study population comprises all patients with
 chronic lymphocytic leukemia (CLL) that have received the indication for treatment with
 Obinutuzumab as per routine clinical practice.
Inclusion Criteria:

 -  Have received at least one dose of Obinutuzumab as per local label and clinical
 practice.

 Exclusion Criteria:

 -  Included in clinical trial